HTEC ROBO Global Healthcare Technology and Innovation ETF

ETF 43.03 Delayed

ETF quote, holdings, sector allocation, technicals, and options analytics. Expected move IV rank history Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

HTEC $43.03 —
Key stats
$43.03
52-Week Range
$30.95 – $45.34
YTD
+21.54%
IV Rank (30D)
31.07
Straddle Price
$2.67
P/C Vol Ratio
0.00
Open
$42.23
Day Range
$42.23 – $43.23
Volume
136,406
Prev Close
$42.12
About

ROBO Global Healthcare Technology and Innovation ETF (HTEC) ETF

No description available.

Exchange
ARCX
Inception
2019-06-24
Has Options
Yes
Fund profile
holdings as of Apr 30, 2026SEC filingthrough Jul 2026flows, SEC filings
Thematic Biotech & Health Innovation#15 of 26 by assets ROBO Internet & Innovation Global Index-tracking
Expense ratio
0.68%
prospectus, filed Aug 26, 2025
Assets
$74M
shares × price, Oct 9, 2026
Trailing yield
0.81%
paid annual
Average daily volume
$2.5M
30 sessions
Holdings
62
top 10 are 22.6%
Listed
Jun 24, 2019
NYSE Arca
Closure risk, 12 months
1.1%
low: size of the sponsor's line-up · model
Tracking difference
-0.86 pts
vs index, after fees, FY 2026
FrenzyCap ETF score
43
how it is built
Cost26
Liquidity47
Scale32
Diversification81

Moves with. US large-cap stocks (24% of its variance, beta 0.86); Small caps over large (14% of its variance, beta 0.66); Gold (3% of its variance, beta 0.08). These factors explain 43% of its daily moves over the last year.

Stated objective. The ROBO Global Healthcare Technology and Innovation ETF (the Fund) seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index (the Index). (from the fund's prospectus)

All 62 holdingsFlow historySimilar fundsOverlap toolAll Biotech & Health Innovation ETFs

Fund flows
through Jul 2026SEC filings
Jul 2026
$0
latest reported month
Latest 3 months
+$7.6M
+11.1% of assets
Latest 12 months
+$14M
+20.2% of assets
Aug 2025: +$3.0MSep 2025: $0SepOct 2025: $0Nov 2025: $0NovDec 2025: $0Jan 2026: $0JanFeb 2026: +$3.3MMar 2026: $0MarApr 2026: $0May 2026: +$7.6M+$7.6MMayJun 2026: $0Jul 2026: $0Jul
View as a table
Net flows of HTEC by month, Aug 2025 to Jul 2026
MonthNet flow
Jul 2026$0
Jun 2026$0
May 2026+$7.6M
Apr 2026$0
Mar 2026$0
Feb 2026+$3.3M
Jan 2026$0
Dec 2025$0
Nov 2025$0
Oct 2025$0
Sep 2025$0
Aug 2025+$3.0M

Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 84 months ago

Similar funds
FundOverlapFeeAssets1Y
HELXFranklin Genomic Advancements ETF27%0.50%$32M+29.2%compare
RSPHInvesco S&P 500 Equal Weight Health Care ETF26%0.40%$887M+24.3%compare
BBHVanEck Biotech ETF23%0.35%$485M+36.9%compare
GNOMGlobal X Genomics & Biotechnology ETF22%0.50%$101M+63.4%compare
XHEState Street SPDR S&P Health Care Equipment ETF22%0.35%$174M+11.2%compare

Ranked by how much of the two portfolios is the same securities.

Look-through: what the holdings say
weights as of Apr 30, 2026SEC filing
Holdings vs fair value
−0.9%
28% under, 47% over · 76% covered
Price / earnings
84.0
40% loss-making · 75% covered
Price / book · sales
4.2 · 4.2
revenue growth +9.9%
Above 200-day average
62%
47% above 50-day · by weight
Short interest
7.6%
of float, weighted · 4.4 days to cover
Insider buying
2%
of weight had net insider buying, 90 days; 60% net selling
13F holders
+4.6%
change in shares held by institutions, latest quarter
Reporting earnings
0.0%
of weight in 7 days; 8.8% in 14
Largest contributors below fair value
INCY+50%BMY+50%IART+50%IQV+38%BMRN+50%
Largest contributors above fair value
AXGN−44%NTRA−34%ISRG−26%GRAL−25%ILMN−24%

Each figure is the fund's holdings weighted by position size, using our data on those stocks, and covers only the share of the stock holdings stated. Positive fair value means the holdings trade below our estimate.

What changed in the portfolio
Jan 31, 2026 → Apr 30, 2026
ActionHoldingWeight beforeWeight afterShares vs flows
ExitRoche Holding AG1.75%——
ExitEXASEXACT SCIENCES CORPORATION1.68%——
New positionRoche Holding AG—1.49%—
ExitCORMASIMO CORPORATION1.27%——
IncreaseAXGNAxoGen, Inc.2.02%3.16%+11.8%
DecreaseMRNAMODERNA, INC.2.20%1.30%−49.5%
IncreaseTEMTEMPUS AI, INC.1.45%2.13%+40.5%
IncreaseALNYALNYLAM PHARMACEUTICALS, INC.1.43%2.01%+36.9%
IncreaseIRTCIRHYTHM HOLDINGS, INC.1.36%1.78%+38.2%
IncreaseIARTINTEGRA LIFESCIENCES HOLDINGS CORPORATION1.03%1.43%+30.4%

1 new, 3 exited, 19 increased and 10 decreased between the fund's two latest holdings reports; turnover 10.1%. Full holdings and history

Under the hood
fiscal year to Apr 30, 2026SEC census
Authorized participants
2 active
of 15 with agreements; top 3 did 100%
Created · redeemed
$3.3M · $3.6M
over the fiscal year
Redemptions in kind
98%
creations 97% in kind
Creation unit
25,000
shares
Securities lending
not authorized
Return vs index
-0.86 pts
after fees; -0.01 before; daily s.d. 0.21

From the fund's annual census filing with the SEC. In-kind redemptions are what let an ETF shed appreciated securities without realising gains.

ETF Profile
holdings as of 2026-04-30
Holdings
62
AUM
$55.0M
Provider
Nport
Inception
2019-06-24
Exchange
ARCX
Data As Of
2026-04-30
Expense Ratio
0.68%
Dividend Yield
0.80%
Distribution
Annual
Recent distributions
Ex-Date Pay Date Amount Type
2025-12-30 2025-12-31 $0.3463 CD
2021-12-28 2021-12-31 $0.0230 CD
Asset Allocation
Top Holdings
top 50 of 62 holdings
Symbol Name Weight % Asset Class Country
MRNA MODERNA, INC. 2.20% Equity (common) US
ARWR ARROWHEAD PHARMACEUTICALS, INC. 2.18% Equity (common) US
GH GUARDANT HEALTH, INC. 2.16% Equity (common) US
ADPT Adaptive Biotechnologies Corp 2.13% Equity (common) US
PEN PENUMBRA, INC. 2.12% Equity (common) US
AXGN AxoGen, Inc. 2.02% Equity (common) US
ILMN ILLUMINA, INC. 2.00% Equity (common) US
VRTX VERTEX PHARMACEUTICALS INCORPORATED 1.99% Equity (common) US
TWST Twist Bioscience Corp 1.97% Equity (common) US
SYK STRYKER CORPORATION 1.96% Equity (common) US
TMO THERMO FISHER SCIENTIFIC INCORPORATED 1.95% Equity (common) US
— EUROFINS SCIENTIFIC SE 1.94% Equity (common) FR
LIVN LIVANOVA PLC 1.88% Equity (common) US
— Siemens Healthineers AG 1.88% Equity (common) DE
BSX BOSTON SCIENTIFIC CORPORATION 1.85% Equity (common) US
— Koninklijke Philips N.V. 1.85% Equity (common) NL
REGN REGENERON PHARMACEUTICALS, INC. 1.84% Equity (common) US
NTRA NATERA, INC. 1.83% Equity (common) US
NOVT NOVANTA INC. 1.82% Equity (common) US
IQV IQVIA HOLDINGS INC 1.80% Equity (common) US
— Lonza Group AG 1.77% Equity (common) CH
— Roche Holding AG 1.75% Equity (common) CH
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 1.73% Equity (common) US
QGEN Qiagen N.V. 1.72% Equity (common) US
MEDP MEDPACE HOLDINGS, INC. 1.71% Equity (common) US
GKOS GLAUKOS CORPORATION 1.70% Equity (common) US
ISRG INTUITIVE SURGICAL, INC. 1.69% Equity (common) US
— JD Health International Inc 1.69% Equity (common) HK
EXAS EXACT SCIENCES CORPORATION 1.68% Equity (common) US
NVCR NOVOCURE LIMITED 1.66% Equity (common) US
GMED GLOBUS MEDICAL, INC. 1.66% Equity (common) US
GRAL Grail Inc 1.65% Equity (common) US
DHR DANAHER CORPORATION 1.65% Equity (common) US
CDNA CAREDX, INC. 1.63% Equity (common) US
INCY INCYTE CORPORATION 1.62% Equity (common) US
— Tecan Group AG 1.62% Equity (common) CH
— DIASORIN S.P.A. 1.60% Equity (common) IT
— EDWARDS LIFESCIENCES CORPORATION 1.58% Equity (common) US
AORT ARTIVION, INC. 1.56% Equity (common) US
— BECTON, DICKINSON AND COMPANY 1.50% Equity (common) US
BMY BRISTOL-MYERS SQUIBB COMPANY 1.50% Equity (common) US
— ABBOTT LABORATORIES 1.45% Equity (common) US
TEM TEMPUS AI, INC 1.45% Equity (common) US
ALNY ALNYLAM PHARMACEUTICALS, INC. 1.43% Equity (common) US
GEHC GE HEALTHCARE TECHNOLOGIES INC. 1.42% Equity (common) US
BMRN BIOMARIN PHARMACEUTICAL INC. 1.41% Equity (common) US
A AGILENT TECHNOLOGIES, INC. 1.38% Equity (common) US
OMCL OMNICELL, INC. 1.37% Equity (common) US
IRTC IRHYTHM HOLDINGS, INC. 1.36% Equity (common) US
— BIO-RAD LABORATORIES, INC. 1.36% Equity (common) US
Geographic Breakdown
Chart
Seasonality
'21'22'23'24'25'26Avg
Jan8.41%-14.21%8.07%-2.44%7.91%3.15%1.82%
Feb-5.34%-3.24%-6.64%1.36%-5.05%-2.59%-3.58%
Mar-6.78%-0.19%0.70%0.27%-4.67%-6.48%-2.86%
Apr4.60%-17.60%2.03%-7.06%0.07%0.18%-2.96%
May-2.45%-3.63%-5.03%3.12%1.64%4.18%-0.36%
Jun7.90%-1.63%2.56%-0.95%5.31%8.12%3.55%
Jul-1.50%6.88%2.55%7.14%-2.19%1.45%2.39%
Aug3.04%-6.33%-5.91%1.89%8.77%8.22%1.61%
Sep-8.02%-8.27%-11.39%2.93%1.45%4.88%-3.07%
Oct2.43%2.84%-10.33%-4.01%6.00%-0.60%*-0.61%
Nov-9.54%3.86%10.20%5.97%8.39%--3.78%
Dec3.75%-5.00%10.09%-6.02%-0.95%--0.37%
Total-5.48%-39.69%-6.09%1.11%28.50%21.36%-0.05%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $43.19
SMA 50: $42.21
SMA 200: $37.01
Current: $43.03
EMA 12: $43.20
EMA 26: $42.89
MACD: 0.3088 | Signal: -0.2115
BULLISH
ADX (14): 24.92
WEAK TREND
+DI: 33.09
−DI: 23.75

Momentum Oscillators

RSI (14): 51.21
NEUTRAL
Stoch %K: 18.53
Stoch %D: 25.78
Williams %R: -62.60

Volume & Volatility

BB Upper: $45.14
BB Lower: $41.23
NEUTRAL
OBV: 273,320
Vol SMA 20: 79,781
Vol ROC: 183.61%
ATR: $0.84
True Range: $1.11
HV 20: 24.4%
HV 30: 22.8%
HV 60: 24.3%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-11T00:00:00 – 2026-10-09T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
All HTEC news →

HTEC Options Activity & IV Rank

HTEC IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 24.7%
7-DTE IV: 38.9%
Expected Move: $2.67
7-DTE Move: $1.50
Days to Exp: 42 (2026-11-20)

Options Flow

Call Volume: 2
Put Volume: 0
P/C Volume: —
BULLISH
Call OI: 1
Put OI: 0
P/C OI: —
Total OI: 1

ATM Options Pricing

ATM Call: $1.35
ATM Put: $1.32
Call %: 3.1%
Put %: 3.1%

Chain Summary

Chain Volume: 129
Chain OI: 128
Last Updated: 10/9/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 9 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 9 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)15.7LowOct 9
IV Rank (30 DTE)31.1MediumOct 9
Straddle Price (30 DTE)$2.67Oct 9
Beta Analysis

Risk Metrics

Beta: 0.8552
Alpha: 19.22%
Correlation: 0.4931
R-Squared: 24.3%
Stock Volatility: 22.6%
Market Volatility: 13.0%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Beta & Alpha Over Time

HTEC Institutional Ownership (13F)

Latest filings — 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

30 filers756,258 shares$28.18M value
# Filer Shares Value % of Total % of Float Period
1 UBS Group AG Custodian 298,175 $11.12M 39.45% — 2026-06-30
2 Morgan Stanley Custodian 105,642 $3.94M 13.98% — 2026-06-30
3 Royal Bank of Canada Custodian 64,534 $2.41M 8.54% — 2026-06-30
4 Tidal Investments LLC 45,589 $1.70M 6.03% — 2026-06-30
5 Citadel Advisors LLC Custodian 23,164 $863.79K 3.06% — 2026-06-30
6 Citigroup Inc. Custodian 23,082 $860.73K 3.05% — 2026-06-30
7 Ellis Investment Partners, LLC 20,003 $745.92K 2.65% — 2026-06-30
8 Arax Advisory Partners Custodian 19,575 $729.95K 2.59% — 2026-06-30
9 Vontobel Holding Ltd. 18,000 $671.22K 2.38% — 2026-06-30
10 Jane Street Group, LLC Custodian 17,961 $669.77K 2.38% — 2026-06-30
11 Raymond James Financial, Inc. Custodian 17,901 $667.53K 2.37% — 2026-06-30
12 LPL Financial LLC Custodian 16,857 $628.59K 2.23% — 2026-06-30
13 Clay Northam Wealth Management, LLC 16,000 $596.64K 2.12% — 2026-06-30
14 Migdal Insurance & Financial Holdings Ltd. 13,286 $495.44K 1.76% — 2026-06-30
15 Stelac Advisory Services LLC 12,800 $477.31K 1.69% — 2026-06-30
16 Beacon Pointe Advisors, LLC 9,113 $339.82K 1.21% — 2026-06-30
17 Capital Square, LLC 8,346 $319.48K 1.13% — 2026-06-30
18 Corient Private Wealth LP 6,878 $256.48K 0.91% — 2026-06-30
19 Regal Investment Advisors LLC 6,727 $250.85K 0.89% — 2026-06-30
20 CWM, LLC Custodian 5,916 $195.36K 0.69% — 2026-03-31
21 OSAIC HOLDINGS, INC. Custodian 3,997 $149.07K 0.53% — 2026-06-30
22 Rockefeller Capital Management L.P. Custodian 1,575 $58.74K 0.21% — 2026-06-30
23 DUNCKER STREETT & CO INC 490 $18.27K 0.06% — 2026-06-30
24 Bullseye Investment Management, LLC 260 $8.59K 0.03% — 2026-03-31
25 Trust Co 126 $5.59K 0.02% — 2026-09-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
55.43K
SI % of Float
3.21%
Days to Cover
2.81
Short Vol Ratio
11.9%
Free Float
—
Float %
—
Short interest 2026-09-30 • Short volume 2026-10-09
HTEC Constituent Performance

Click any bar to view the full quote for that stock.

HTEC Constituents (45 of 45)
Symbol Name Weight % Price 1 Day 1 Week 1 Month
MRNA MODERNA, INC. 2.20% $225 +14.21%+18.41%+56.28%
ARWR ARROWHEAD PHARMACEUTICALS, INC. 2.18% $62.75 +3.31%-2.24%-24.26%
GH GUARDANT HEALTH, INC. 2.16% $167.47 +1.15%-5.81%+6.41%
ADPT Adaptive Biotechnologies Corp 2.13% $26.49 +1.53%-6.56%+9.46%
PEN PENUMBRA, INC. 2.12% $319.4 +0.59%+0.58%+0.53%
AXGN AxoGen, Inc. 2.02% $36.13 -0.14%-3.37%-14.30%
ILMN ILLUMINA, INC. 2.00% $278.17 +5.14%+1.88%+34.74%
VRTX VERTEX PHARMACEUTICALS INCORPORATED 1.99% $510.08 +1.36%+1.06%-1.04%
TWST Twist Bioscience Corp 1.97% $159.78 +5.08%-15.31%+25.59%
SYK STRYKER CORPORATION 1.96% $277.33 +0.13%+0.69%+0.64%
TMO THERMO FISHER SCIENTIFIC INCORPORATED 1.95% $658.02 +0.93%+0.49%+7.90%
LIVN LIVANOVA PLC 1.88% $76.39 +0.63%+1.76%-2.29%
BSX BOSTON SCIENTIFIC CORPORATION 1.85% $42.73 +1.64%+0.31%-0.58%
REGN REGENERON PHARMACEUTICALS, INC. 1.84% $746.54 +0.94%+1.54%-4.47%
NTRA NATERA, INC. 1.83% $400.71 +2.54%-2.35%+21.82%
NOVT NOVANTA INC. 1.82% $141.28 +3.63%-5.35%-3.60%
IQV IQVIA HOLDINGS INC 1.80% $259.88 +0.39%+0.65%-0.72%
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 1.73% $301.79 +1.27%+4.00%+8.46%
QGEN Qiagen N.V. 1.72% $45.38 +1.91%+1.41%+6.78%
MEDP MEDPACE HOLDINGS, INC. 1.70% $612.05 +1.55%+2.10%+4.18%
GKOS GLAUKOS CORPORATION 1.70% $165.69 +2.73%+1.18%-0.93%
ISRG INTUITIVE SURGICAL, INC. 1.69% $423.96 +2.06%+8.17%+14.85%
EXAS EXACT SCIENCES CORPORATION 1.68% $104.91 +0.95%+1.29%+1.43%
NVCR NOVOCURE LIMITED 1.66% $14.58 +2.53%-2.41%-6.00%
GMED GLOBUS MEDICAL, INC. 1.66% $74.65 +1.80%-1.26%+0.62%
GRAL Grail Inc 1.65% $140.58 +6.01%-1.87%+81.25%
DHR DANAHER CORPORATION 1.65% $219.81 +1.08%+2.69%+9.83%
CDNA CAREDX, INC. 1.63% $63.67 +2.36%-5.18%+26.68%
INCY INCYTE CORPORATION 1.62% $112.79 +0.04%-2.18%-7.15%
AORT ARTIVION, INC. 1.56% $21.26 +0.24%-4.71%-15.23%
BMY BRISTOL-MYERS SQUIBB COMPANY 1.50% $59.12 -0.77%-3.32%-7.10%
TEM TEMPUS AI, INC 1.45% $70.93 +2.38%-7.44%+20.20%
ALNY ALNYLAM PHARMACEUTICALS, INC. 1.43% $232.68 +3.63%+5.90%-6.43%
GEHC GE HEALTHCARE TECHNOLOGIES INC. 1.42% $65.74 +2.37%+2.26%+2.83%
BMRN BIOMARIN PHARMACEUTICAL INC. 1.41% $54.8 -0.17%-4.17%-16.57%
A AGILENT TECHNOLOGIES, INC. 1.38% $170.54 +1.41%+1.65%+16.07%
OMCL OMNICELL, INC. 1.37% $35.82 +2.84%+6.61%+9.24%
IRTC IRHYTHM HOLDINGS, INC. 1.36% $106.7 +4.00%-3.33%-4.24%
UTHR UNITED THERAPEUTICS CORPORATION 1.34% $549.16 +3.07%+1.38%+10.47%
COR MASIMO CORPORATION 1.27% $323.85 +0.78%+4.79%+0.71%
VCYT Veracyte Inc 1.26% $45.23 +3.74%-1.27%+10.67%
CNMD CONMED CORPORATION 1.24% $44.42 -1.53%-4.10%-4.06%
RVTY REVVITY, INC. 1.15% $154.18 +1.33%+1.75%+24.03%
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION 1.03% $13.44 +0.22%+5.99%-13.29%
VEEV VEEVA SYSTEMS INC. 0.94% $296.13 +3.96%+8.34%+12.85%